The role of bone marrow edema and lymphangiogenesis in inflammatory-erosive arthritis

Advances in Experimental Medicine and Biology

Volumn 658, Issue , 2010, Pages 1-10

  Schwarz, Edward M ^a   Proulx, Steven T ^b   Ritchlin, Christopher T ^b   Boyce, Brendan F ^b   Xing, Lianping ^b  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b NONE

Author keywords

3D MRI; In vivo imaging; Inflammatory arthritis; Lymphangiogenesis

Indexed keywords

CD11B ANTIGEN; CHEMOKINE RECEPTOR CXCR4; GADOLINIUM; GROWTH FACTOR; OSTEOCLAST DIFFERENTIATION FACTOR; STROMAL CELL DERIVED FACTOR 1; TUMOR NECROSIS FACTOR ANTIBODY; VASCULOTROPIN C;

ARTHRITIS; BONE EROSION; BONE MARROW EDEMA; BONE RADIOGRAPHY; CATABOLISM; CELL DIFFERENTIATION; CONFERENCE PAPER; CONTRAST ENHANCEMENT; CYTOKINE PRODUCTION; DISEASE SEVERITY; DOWN REGULATION; HUMAN; IMMUNOHISTOCHEMISTRY; INCIDENCE; INFLAMMATORY EROSIVE ARTHRITIS; LYMPH NODE; LYMPHANGIOGENESIS; MOLECULAR DYNAMICS; MYELOPOIESIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; ONCOGENE; OSTEOCLAST; OSTEOCLASTOGENESIS; OUTCOME ASSESSMENT; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; STEM CELL; SYNOVIOCYTE; SYNOVITIS;

ANIMALS; ARTHRITIS; BIOLOGICAL MARKERS; BONE MARROW; BONE MARROW CELLS; CELL MOVEMENT; CELL PROLIFERATION; CHEMOKINE CXCL12; CONTRAST MEDIA; EDEMA; INFLAMMATION; JOINTS; LYMPHANGIOGENESIS; MAGNETIC RESONANCE IMAGING; MICE; MYELOPOIESIS; OSTEOCLASTS; OSTEOGENESIS; RANK LIGAND; RECEPTOR, MACROPHAGE COLONY-STIMULATING FACTOR; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR C;

MUS;

EID: 79959563015     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4419-1050-9_1     Document Type: Conference Paper

References (41)

1. Appel H. Kuhne M. Spiekermann S. Kohler D. Zacher J. Stein H. et al. 2006 Immunohistochemical analysis of hip arthritis in ankylosing spondylitis: evaluation of the bone-cartilage interface and subchondral bone marrow. Arthritis Rheum 5461805-1813. (Pubitemid 43877930)
2. Appel H. Loddenkemper C. Grozdanovic Z. Ebhardt H. Dreimann M. Hempfing A. et al. 2006 Correlation of histopathological findings and magnetic resonance imaging in the spine of patients with ankylosing spondylitis. Arthritis Res Ther 85R143
3. Anandarajah A.P. Schwarz E.M. Totterman S. Monu J. Feng C.Y. Shao T. et al. 2008 The effect of etanercept on osteoclast precursor frequency and enhancing bone marrow oedema in patients with psoriatic arthritis. Ann Rheum Dis 673296-301. (Pubitemid 351281261)
4. Benton N. Stewart N. Crabbe J. Robinson E. Yeoman S. & McQueen F.M. 2004MRI of the wrist in early rheumatoid arthritis can be used to predict functional outcome at 6 years. Ann Rheum Dis 635555-561. (Pubitemid 38530200)
5. Boyce B.F. Schwarz E.M. & Xing L. 2006 Osteoclast precursors: cytokine-stimulated immunomodulators of inflammatory bone disease. Curr Opin Rheumatol 184(4)27-432. (Pubitemid 44297290)
6. Bradfield P.F. Amft N. Vernon-Wilson E. Exley A.E. Parsonage G. Rainger G.E. et al. 2003 Rheumatoid fibroblast-like synoviocytes overexpress the chemokine stromal cell-derived factor 1 CXCL12) which supports distinct patterns and rates of CD4+ and CD8+ T cell migration within synovial tissue. Arthritis Rheum 4892472-2482. (Pubitemid 37129424)
7. Conaghan P.G. McQueen F.M. Peterfy C.G. Lassere M.N. Ejbjerg B. Bird P. et al. 2005 The evidence for magnetic resonance imaging as an outcome measure in proof-ofconcept rheumatoid arthritis studies. J Rheumatol 32122465-2469. (Pubitemid 41780670)
8. Dohn U.M. Ejbjerg B.J. Court-Payen M. Hasselquist M. Narvestad E. Szkudlarek M. et al. 2006 Are bone erosions detected by magnetic resonance imaging and ultrasonography true erosions? A comparison with computed tomography in rheumatoid arthritis metacarpophalangeal joints. Arthritis Res Ther 84R110.
9. Feldmann M. & Maini R.N. 2003 Lasker Clinical Medical Research Award. TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases. Nat Med 9101245-1250. (Pubitemid 37279838)
10. Haavardsholm E.A. Ostergaard M. Ejbjerg B.J. Kvan N.P. Uhlig T.A. Lilleas F.G. et al. 2005 Reliability and sensitivity to change of the OMERACT rheumatoid arthritis magnetic resonance imaging score in a multireader longitudinal setting. Arthritis Rheum 52123860-3867. (Pubitemid 41798224)
11. Jimenez-Boj E. Nobauer-Huhmann I. Hanslik-Schnabel B. Dorotka R. Wanivenhaus A.H. Kainberger F. et al. 2007 Bone erosions and bone marrow edema as defined by magnetic resonance imaging reflect true bone marrow inflammation in rheumatoid arthritis. Arthritis Rheum 5641118-1124. (Pubitemid 46608636)
12. Jimenez-Boj E. Redlich K. Turk B. Hanslik-Schnabel B. Wanivenhaus A. Chott A. et al. 2005 Interaction between synovial inflammatory tissue and bone marrow in rheumatoid arthritis. J Immunol 17542579-2588. (Pubitemid 41113871)
13. Keffer J. Probert L. Cazlaris H. Georgopoulos S. Kaslaris E. Kioussis D. et al. 1991 Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis. Embo J 10134025-4031. (Pubitemid 21905432)
14. Kirkham B.W. Lassere M.N. Edmonds J.P. Juhasz K.M. Bird P.A. Lee C.S. et al. 2006 Synovial membrane cytokine expression is predictive of joint damage progression in rheumatoid arthritis: a two-year prospective study the DAMAGE study cohort Arthritis Rheum 5441122-1131. (Pubitemid 43672925)
15. Kitaura H. Zhou P. Kim H.J. Novack D.V. Ross F.P. & Teitelbaum S.L.2005 M-CSF mediates TNF-induced inflammatory osteolysis. J Clin Invest 115123418-3427 (Pubitemid 43121830)
16. Kuek A. Hazleman B.L. & Ostor A.J. 2007 Immune-mediated inflammatory diseases (IMIDs) and biologic therapy: a medical revolution. Postgrad MedJ 83978251-260. (Pubitemid 46663012)
17. Li P. Schwarz E.M. O'Keefe R.J. Ma L. Boyce B.F. & Xing L. 2004 RANK signaling is not required for TNFalpha-mediated increase in (CD11hi) osteoclast precursors but is essential for mature osteoclast formation in TNFalpha-mediated inflammatory arthritis. J Bone Miner Res 19(2)207-213. (Pubitemid 38116734)
18. Li P. Schwarz E.M. O'Keefe R.J. Ma L. Looney R.J. Ritchlin C.T. et al. 2004 Systemic tumor necrosis factor alpha mediates an increase in peripheral CD11bhigh osteoclast precursors in tumor necrosis factor alpha-transgenic mice. Arthritis Rheum 50(1)265-276. (Pubitemid 38084312)
19. Martinez-Martinez M.U. Cuevas-Orta E. Reyes-Vaca G. Baranda L. Gonzalez-Amaro R. & Abud-Mendoza C. 2007 Magnetic resonance imaging in patients with rheumatoid arthritis with complete remission treated with disease-modifying antirheumatic drugs or antitumour necrosis factor alpha agents. Ann Rheum Dis 66(1)134-135. (Pubitemid 46049689)
20. Maruyama K. Asai J. Ii M. Thorne T. Losordo D.W. & D'Amore P.A. 2007 Decreased macrophage number and activation lead to reduced lymphatic vessel formation and contribute to impaired diabetic wound healing. Am J Pathol 17041178-1191 (Pubitemid 47339326)
21. McGonagle D. Conaghan P.G. O'Connor P. Gibbon W. Green M. Wakefield R. et al. 1999 The relationship between synovitis and bone changes in early untreated rheumatoid arthritis: a controlled magnetic resonance imaging study. Arthritis Rheum 4281706-1711. (Pubitemid 30263640)
22. McQueen F.M. 2000 Magnetic resonance imaging in early inflammatory arthritis: what is its role? Rheumatology 39(7)700-706. (Pubitemid 30487891)
23. McQueen F.M. & Ostendorf B. 2006 What is MRI bone oedema in rheumatoid arthritis and why does it matter? Arthritis Res Ther 8(6)222.
24. Oliver G. & Detmar M. 2002 The rediscovery of the lymphatic system: old and new insights into the development and biological function of the lymphatic vasculature. Genes Dev 16(7)773-783. (Pubitemid 34280101)
25. Ostergaard M. Hansen M. Stoltenberg M. Gideon P. Klarlund M. Jensen K.E. & Lorenzen I. 1999 Magnetic resonance imaging-determined synovial membrane volume as a marker of disease activity and a predictor of progressive joint destruction in the wrists of patients with rheumatoid arthritis. Arthritis Rheum 42(5)918-929. (Pubitemid 29215002)
26. Pablos J.L. Santiago B. Galindo M. Torres C. Brehmer M.T. Blanco F.J. et al. 2003 Synoviocyte-derived CXCL12 is displayed on endothelium and induces angiogenesis in rheumatoid arthritis. J Immunol 170(4)2147-2152. (Pubitemid 36197438)
27. Ponomaryov T. Peled A. Petit I. Taichman R.S. Habler L. Sandbank J. et al. 2000 Induction of the chemokine stromal-derived factor-1 following DNA damage improves human stem cell function. J Clin Invest 106(11)1331-1339.
28. Proulx S.T. Kwok E. You Z. Beck C.A. Shealy D.J. Ritchlin C.T. et al. 2007 MRI and quantification of draining lymph node function in inflammatory arthritis. Ann N Y Acad Sci 1117:106-123. (Pubitemid 350191267)
29. Proulx S.T. Kwok E. You Z. Papuga M.O. Beck C.A. Shealy D.J. et al. 2008 Elucidating bone marrow edema and myelopoiesis in murine arthritis using contrast-enhanced magnetic resonance imaging. Arthritis Rheum 58(7)2019-2029. (Pubitemid 351988094)
30. Proulx S.T. Kwok E. You Z. Papuga M.O. Beck C.A. Shealy D.J. et al. 2007 Longitudinal assessment of synovial lymph node and bone volumes in inflammatory arthritis in mice by in vivo magnetic resonance imaging and microfocal computed tomography. Arthritis Rheum 56(12)4024-4037. (Pubitemid 350262330)
31. Ritchlin C.T. Haas-Smith S.A. Li P. Hicks D.G. & Schwarz E.M. 2003 Mechanisms of TNF-alpha- and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis. J Clin Invest 111(6)821-831. (Pubitemid 37074957)
32. Salven P. Lymboussaki A. Heikkila P. Jaaskela-Saari H. Enholm B. Aase K. et al. 1998 Vascular endothelial growth factors VEGF-B and VEGF-C are expressed in human tumors. Am J Pathol 153(1)103-108. (Pubitemid 28317512)
33. Schwarz E.M. Looney R.J. Drissi M.H. O'Keefe R.J. Boyce B.F. Xing L. & Ritchlin C.T. 2006 Autoimmunity and bone. Ann N Y Acad Sci 1068:275-283. (Pubitemid 43824159)
34. Shealy D.J.Woo ley P.H. Emmell E. Volk A. Rosenberg A. Treacy G. et al. 2002 Anti-TNF-alpha antibody allows healing of joint damage in polyarthritic transgenic mice. Arthritis Res 45R7.
35. Su J.L. Yen C.J. Chen P.S. Chuang S.E. Hong C.C. Kuo I.H. et al. 2007 The role of the VEGF-C/VEGFR-3 axis in cancer progression. Br J Cancer 964541-545.
36. Yu X. Huang Y. Collin-Osdoby P. & Osdoby P. 2003 Stromal cell-derived factor-1 SDF-1) recruits osteoclast precursors by inducing chemotaxis matrix metalloproteinase-9 MMP-9) activity and collagen transmigration. J Bone Miner Res 18(8)1404-1418. (Pubitemid 41070795)
37. Xing L. Schwarz E.M. & Boyce B.F. 2005 Osteoclast precursors RANKL/RANK and immunology. Immunol Rev 208:19-29.
38. Yao Z. Li P. Zhang Q. Schwarz E.M. Keng P. Arbini A. et al. 2006 Tumor Necrosis Factor-{alpha} Increases Circulating Osteoclast Precursor Numbers by Promoting Their Proliferation and Differentiation in the Bone Marrow through Up-regulation of c-Fms Expression. J Biol Chem 281(17)11846-11855. (Pubitemid 43855445)
39. Zhang Q. Guo R. Lu Y. Zhao L. Zhou Q. Schwarz E.M. et al. 2008 VEGF-C a Lymphatic Growth Factor Is a RANKL Target Gene in Osteoclasts That Enhances Osteoclastic Bone Resorption through an Autocrine Mechanism. J Biol Chem 283(19)13491-13499.
40. Zhang Q. Guo R. Schwarz E.M. Boyce B.F. & Xing L. 2008 TNF inhibits production of SDF-1 by bone stromal cells and increases osteoclast precursor mobilization from bone marrow to peripheral blood. Arthritis Res Ther 10(2)R37.
41. Zhang Q. Lu Y. Proulx S. Guo R. Yao Z. Schwarz E.M. et al. 2007 Increased lymphangiogenesis in joints of mice with inflammatory arthritis. Arthritis Res Ther 9(6)R118.